2024 CBIIC in Guangzhou on November 30 - December 2, 2024.
Mr. Kuan CHEN, Senior Engineer, Founder, Chairman of the Board and Executive Director of Infervision, was a Ph.D. candidate pursuing dual doctoral degrees in Economics and Finance at the University of Chicago, where he studied under the guidance of four Nobel Prize winners.
Mr. Chen founded Infervision in 2016, whose mission is to improve human life with AI. Infervision is an Artificial Intelligence (AI) medical technology company dedicated to developing AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple